| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.3M | -10.3% | -16.5% |
| Cost of Revenue | $1.3M | -11.6% | -9.3% |
| Gross Profit | $1.9M | -9.4% | -20.8% |
| R&D Expense | $139K | +35.8% | +24.1% |
| SG&A Expense | $822K | -24.3% | -24.1% |
| Operating Income | -$181K | -34.5% | -201.0% |
| Net Income | -$204K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.7M | -11.2% | -30.4% |
| Accounts Receivable | $2.0M | +13.7% | +33.9% |
| Inventory | $1.0M | +56.5% | +24.2% |
| Current Assets | $5.0M | +8.8% | -3.9% |
| Total Assets | $17.8M | +1.9% | +6.8% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $210K | — | — |
| Capital Expenditures | $254K | — | — |
| Investing Cash Flow | -$254K | — | — |
| Financing Cash Flow | -$204K | — | — |
| Free Cash Flow | -$44K | — | — |
| -26.6% |
| -235.5% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| $3.7M |
| +18.7% |
| +12.8% |
| Total Liabilities | $13.8M | +3.8% | +8.5% |
| Stockholders' Equity | $4.1M | -4.0% | +1.5% |